sodium bicarbonate 1.4 FKI 500ML
Active SODIUM BICARBONATE
Group therapeutic intravenous solutions
Product Type GENERIC DRUG MAKES NO SSN scheme
Class C Type RR Recipe - Repeat
Form Farm. INJECTIONS container BOTTLE
Commerc Data valid for 24 months. Producer Price
ATC B05BB01
FRESENIUS KABI ITALY Srl
Pharmacotherapeutic
Rehydrating. Alkalizing.
INDICATIONS For the treatment of states of metabolic acidosis and intossicazio
ni barbiturate, salicylate, methyl alcohol, which
hemolytic syndromes, syndromes rabdomiolitiche and hyperuricemia. E 'shown in
intestinal losses of bicarbonate (diarrhea) and in shock.
CONTRAINDICATIONS / EFF.SECONDAR
not use in patients with metabolic or respiratory alkalosis, if specific species
hypochloraemic (vomiting, gastrointestinal losses, diuretics therapy
policy).
DOSAGE
intravenously. The dose and 'age-dependent', weight,
patient's clinical condition. In subacute and chronic forms of acidosis meta bolic
administered 2 to 5 mEq of bicarbonate per kg Corpor
eo during 4-8 hours. In children administered very slowly, and not more
'of 8 mEq / kg of body weight per day to avoid diminution de lla
cerebrospinal pressure and possible intracranial hemorrhage. It
c ouncil not get a full correction of acidosis in the first 24
hours, to avoid alkalosis due to a subsequent overcompensation
breathing.
INTERACTIONS
If used to dilute drugs consult your pharmacist if
AVAILABLE ile before introducing the drug additives, however, consider the characteristics of AC
products to be introduced;
aseptic techniques. Please refer to the medical literature specific user.
SIDE EFFECTS
metabolic alkalosis, hypernatremia, cellulite chemical necrosis
tissu to accidental extravasation in the soft tissues. Febrile episodes
inf ection at the site of injection, venous thrombosis or phlebitis. If
adverse reaction, stop the administration and maintain par
you not given for any examinations.
0 comments:
Post a Comment